Evaluation of a Rapid Whole Blood ELISA for Quantification of Troponin I in Patients with Acute Chest Pain
Open Access
- 1 October 1999
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 45 (10) , 1789-1796
Abstract
Background: Troponin I (cTnI) provides important prognostic information in patients with chest pain. We wished to evaluate a rapid, whole-blood analyzer for quantitative point-of-care testing. Methods: A quantitative point-of-care test system (Stratus CS®; Dade-Behring) for cTnI with an incorporated centrifuge was evaluated in 412 patients with chest pain less than 12 h. Results: Results were available within 15 min. CVs were 4.5% at 0.1 μg/L, 4.2% at 0.25 μg/L, and 6.5% at 0.82 μg/L. The detection limit was 0.01 μg/L. The 97.5% percentile in a healthy population was 0.08 μg/L. Based on ROC curve analysis, a threshold of 0.15 μg/L was calculated for the detection of acute myocardial infarction (AMI). With it, sensitivity for the detection of patients with AMI (n = 62) was 63% at arrival and 98% after 4 h (Stratus II®, 48% and 85%, respectively; P P Conclusion: The Stratus CS provided better analytical performance and comparable or better prognostic information than the Stratus II.Keywords
This publication has 28 references indexed in Scilit:
- Benefit of Abciximab in Patients with Refractory Unstable Angina in Relation to Serum Troponin T LevelsNew England Journal of Medicine, 1999
- The Electrocardiogram Predicts One-Year Outcome of Patients With Unstable Angina and Non–Q Wave Myocardial Infarction: Results of the TIMI III Registry ECG Ancillary Study fn1fn1The TIMI III Clinical Centers are supported by Grant R01-HL42311 and the Data Coordinating Center by Grant R01-HL42428 from the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland. Additional support was supplied by Genentech, Inc., South San Francisco, California.JACC, 1997
- Troponin T Identifies Patients With Unstable Coronary Artery Disease Who Benefit From Long-Term Antithrombotic ProtectionJACC, 1997
- Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1996
- Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial IschemiaNew England Journal of Medicine, 1996
- Value of Myoglobin, Troponin T, and CK-MB mass in Ruling Out an Acute Myocardial Infarction in the Emergency RoomCirculation, 1995
- Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarctionJACC, 1995
- Failure of new biochemical markers to exclude acute myocardial infarction at admissionThe Lancet, 1993
- The Prognostic Value of Serum Troponin T in Unstable AnginaNew England Journal of Medicine, 1992
- Use of the Initial Electrocardiogram to Predict In-Hospital Complications of Acute Myocardial InfarctionNew England Journal of Medicine, 1985